CHI Advisors LLC
- SEC CIK
- 0001791468
- Latest filing
- Nov 13, 2023
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed May 14, 2021. Long positions only.
- Positions
- 21
- No 13F data for Q4 2020
- Portfolio value
- $499.5M
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CGEMCullinan Therapeutics, Inc. | COM | 2,202,407 | $91.8M | 18.4% | – | – | History |
| PLRXPliant Therapeutics, Inc. | COM | 2,324,795 | $91.4M | 18.3% | – | – | History |
| RPTXRepare Therapeutics Inc. | COM | 2,560,703 | $78.6M | 15.7% | – | – | History |
| RXDXPrometheus Biosciences, Inc. | COM | 2,874,032 | $52.5M | 10.5% | – | – | History |
| ORTXOrchard Therapeutics plc | ADS | 4,051,972 | $29.4M | 5.9% | – | – | History |
| ONCROncorus, Inc. | COM | 1,771,786 | $24.7M | 4.9% | – | – | History |
| KROSKeros Therapeutics, Inc. | COM | 400,468 | $24.6M | 4.9% | – | – | History |
| IMAImageneBio, Inc. | COM | 814,756 | $23.0M | 4.6% | – | – | History |
| LRMRLarimar Therapeutics, Inc. | COM | 1,515,148 | $22.1M | 4.4% | – | – | History |
| INZYInozyme Pharma, Inc. | COM | 927,264 | $18.4M | 3.7% | – | – | History |
| Freeline Therapeutics Hldgs35655L107 | SPONSORED ADS | 1,384,743 | $17.0M | 3.4% | – | – | – |
| AKUSAkouos, Inc. | COM | 858,027 | $11.9M | 2.4% | – | – | History |
| DTILPrecision Biosciences Inc | COM | 691,629 | $7.16M | 1.4% | – | – | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 679,132 | $2.09M | 0.4% | – | – | History |
| GTHXG1 Therapeutics, Inc. | COM | 50,000 | $1.20M | 0.2% | – | – | History |
| KZRKezar Life Sciences, Inc. | COM | 174,169 | $1.04M | 0.2% | – | – | History |
| OVIDOvid Therapeutics Inc. | COM | 247,510 | $995.0K | 0.2% | – | – | History |
| GBTGlobal Blood Therapeutics, Inc. | COM | 15,000 | $611.0K | 0.1% | – | – | History |
| ADVMAdverum Biotechnologies, Inc. | COM | 40,209 | $396.0K | 0.1% | – | – | History |
| BPMCBlueprint Medicines Corp | COM | 3,500 | $340.0K | 0.1% | – | – | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 2,000 | $228.0K | <0.1% | – | – | History |